Developers: | Brain Navi |
Date of the premiere of the system: | August, 2020 |
Branches: | Pharmaceutics, medicine, health care |
Technology: | Robotics |
2020: The announcement of the robot which takes dabs from a nose for tests for COVID-19
In the middle of August, 2020 the Taiwan firm Brain Navi provided the new robot who independently takes dabs from a nose. Developers hope that thanks to this robot medical institutions will be able to hold expanded testing on the COVID-19 activator, at the same time reducing risk of its further distribution.
Mass testing became a cornerstone of prevention of COVID-19 as it is possible bigger number of people on the SARS-CoV-2 virus. However the procedure of taking of dab from a nose puts at risk of the doctor which executes it, and the medic who instructs the patient about holding a procedure. The robot who takes dabs from a nose can bypass this contradiction and provide safe testing.
The Brain Navi company presented the new robot at the Bio Asia Taiwan 2020 exhibition where he was seen even by the president of Taiwan. The device uses a face recognition technique to define location of nostrils and to take dab. After the patient fixes the head on a rack, all elements of the procedure are made automatically, and eventually the sample gets to the closed container safe for the address.
At the same time the robot for taking of dab from a nose of Brain Navi uses some fundamental NaoTrac functions - the neurosurgical navigation robot developed by Brain Navi. It successfully passed clinical trials and was already used at more than ten transactions in the Taiwan medical center Hualien by Zi-Chi.
The Brain Navi robot for taking of dabs from a nose is not approved yet by regulatory bodies, but developers got permission to clinical trials on Taiwan. The Brain Navi company hopes to get the emergency permission of regulatory bodies to use of the robot in the USA. It is expected that the robot will appear in hospitals in the second half of 2020.[1]